Screener
Gyre Therapeutics, Inc. GYRE Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
FAQ
- What is Gyre Therapeutics, Inc.'s net margin?
- Gyre Therapeutics, Inc. (GYRE) reported net margin of -13.4% in Q2 2026.
- How has Gyre Therapeutics, Inc.'s net margin changed year-over-year?
- Gyre Therapeutics, Inc.'s net margin decreased by 891.7% year-over-year, from 1.7% to -13.4%.
- What is the long-term trend for Gyre Therapeutics, Inc.'s net margin?
- Over 4 years (2020 to 2025), Gyre Therapeutics, Inc.'s net margin has grown at a -64.6% compound annual growth rate (CAGR), from -268.5% to 4.2%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Gyre Therapeutics, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude